Huadong Medicine (HD Medicine)

Historical price data

Huadong Medicine's mission is to become a global leader in pharmaceutical innovation, improving human health through the discovery and delivery of high-quality medicines. The company has achieved significant scale as one of China's largest and most valuable publicly traded pharma firms, with a robust commercial portfolio and a maturing R&D pipeline. Its strategy hinges on a dual approach: deepening its presence in the massive domestic market through commercialization and partnerships, while advancing a proprietary pipeline of novel biologics and small molecules to compete globally. Sustained high R&D investment and strategic business development are central to this growth plan.

A fully integrated platform spanning small molecule discovery, monoclonal antibody and ADC development, and large-scale commercial manufacturing for both chemical and biological drugs.

Huadong competes directly with other Chinese pharma innovators like Hengrui and BeiGene, leveraging its integrated commercial and manufacturing scale. It also contends with multinational corporations in China and, for its global assets, must eventually prove competitive against established global standards of care.